Gomez-Arteaga, Alexandra http://orcid.org/0000-0003-0897-3790
Scordo, Michael
Tamari, Roni
Ruiz, Josel D.
Jakubowski, Ann A.
Papadopoulos, Esperanza B.
Giralt, Sergio A.
Perales, Miguel-Angel
Castro-Malaspina, Hugo R.
Sauter, Craig S.
Dahi, Parastoo B. http://orcid.org/0000-0002-0794-3226
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
U.S. Department of Health & Human Services | National Institutes of Health (P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 22 April 2020
Revised: 27 April 2020
Accepted: 29 April 2020
First Online: 18 May 2020
Compliance with ethical standards
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests—PBD: Serves on the scientific advisory board of Kite—A Gilead Company. SAG: Consultancy for Amgen, Actinium, Celgene, Johnson & Johnson, Takeda, Jazz Pharmaceuticals, Novartis, Kite, Spectrum Pharmaceuticals. Research support for clinical trials from Amgen, Actinium, Celgene, Johnson & Johnson, Takeda, and Miltenyi. MAP: Honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. Research support for clinical trials from Incyte, Kite (Gilead) and Miltenyi Biotec. MS: Consultancy for McKinsey & Company, Omeros Corporation, and Angiocrine Bioscience. Has served ad hoc on the scientific advisory board of Kite—A Gilead Company. Research support for clinical trials from Angiocrine Bioscience. CSS: Has served as a paid consultant on advisory boards for: Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Genmab, Precision Biosciences, Kite, a Gilead Company, Celgene, Gamida Cell and GSK. Research support for clinical trials Juno Therapeutics, Celgene, Precision Biosciences and Sanofi-Genzyme.